Evidence map›Paper›PMID 30429824›Full record

ArticleFrontiers in neurology2018

Inhibition of p38 MAPK Signaling Regulates the Expression of EAAT2 in the Brains of Epileptic Rats.

Zhang Yang, Jing Wang, Changyin Yu, Ping Xu, Jun Zhang, Yan Peng, Zhong Luo, Hao Huang, Junwei Zeng, Zucai Xu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Activated protein C in epilepsy pathophysiology.Frontiers in neuroscience · 2023
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Uncovering the Pharmacological Mechanism ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zhang YangDepartment of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Jing WangDepartment of Prevention and Health Care, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Changyin YuDepartment of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Ping XuDepartment of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Jun ZhangDepartment of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yan PengDepartment of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zhong LuoDepartment of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Hao HuangDepartment of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Junwei ZengDepartment of Physiology, Zunyi Medical University, Zunyi, China.
Zucai XuDepartment of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zunyi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seizures induce the release of excitatory amino acids (EAAs) from the intracellular fluid to the extracellular fluid, and the released EAAs primarily comprise glutamic acid (Glu) and asparaginic acid (Asp). Glu neurotransmission functions via EAA transporters (EAATs) to maintain low concentrations of Glu in the extracellular space and avoid excitotoxicity. EAAT2, the most abundant Glu transporter subtype in the central nervous system (CNS), plays a key role in the regulation of glutamate transmission. Previous studies have shown that SB203580 promotes EAAT2 expression by inhibiting the p38 mitogen-activated protein kinase (MAPK) signaling pathway, but whether SB203580 upregulates EAAT2 expression in epileptic rats is unknown. This study demonstrated that EAAT2 expression was increased in the brain tissue of epileptic rats. Intraperitoneal injection of a specific inhibitor of p38 MAPK, SB203580, reduced the time to the first epileptic seizure and attenuated the seizure severity. In addition, SB203580 treatment increased the EAAT2 expression levels in the brain tissue of epileptic rats. These results suggest that SB203580 could regulate epileptic seizures via EAAT2.

Indexed as

epilepsyexcitatory amino acidsglutamic acidp38 mitogen-activated protein kinaseSB203580

Identifiers

PMID30429824
PMCPMC6220601
OpenAlexW2899029643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.